reports
- Richard Williamson
- Richard Williamson
Doctor Care Anywhere Group - Making progress towards profitability
Doctor Care Anywhere Group’s (DOC) Q122 results showed continuing revenue momentum from FY21, as well as a significant expansion in its gross margin as the costs of delivering consultations reverted to more normalised levels. Over the quarter, DOC significantly reduced its overheads and believes the platform’s operating leverage will allow it to scale and reach its goal of EBITDA run-rate profitability by H123.
- Richard Williamson
Doctor Care Anywhere Group - Growth company focused on profitability
Doctor Care Anywhere Group (DOC) is a fast-growing telehealth company focused on the private healthcare sector. Following its successful IPO in December 2020, the group delivered a strong performance in its first year of trading and achieved several of the goals set out in its prospectus. At the end of 2021, management outlined its plan for profitable growth, underpinned by its new operating model and updated master services agreement with AXA Health. We have reflected this in our updated foreca...
- Richard Williamson
Doctor Care Anywhere Group - Growth achieved, now looking to profitabi...
Doctor Care Anywhere Group (DOC) reported 116% revenue growth in its FY21 trading update, significantly ahead of its 100% growth target for the year. Growth was driven by a 94% y-o-y increase in the number of consultations delivered on DOC’s platform, which accelerated towards the end of the year as supply constraints on GPs eased. Looking ahead, management’s newly announced operating model should support more profitable scalability by diversifying its blend of services.
- Richard Williamson
Doctor Care Anywhere Group - Growth achieved, now looking to profitabi...
Doctor Care Anywhere Group (DOC) reported 116% revenue growth in its FY21 trading update, significantly ahead of its 100% growth target for the year. Growth was driven by a 94% y-o-y increase in the number of consultations delivered on DOC’s platform, which accelerated towards the end of the year as supply constraints on GPs eased. Looking ahead, management’s newly announced operating model should support more profitable scalability by diversifying its blend of services.
- Richard Williamson
Doctor Care Anywhere Group - Seizing the market opportunity
Doctor Care Anywhere Group’s (DOC) Q321 results highlight that revenue has continued to grow throughout the year, with performance in Q3 driven by a return to q-o-q growth in consultations. Following positive momentum, management has reiterated guidance for FY21 of at least 100% y-o-y organic revenue growth. Through its continuing GP recruitment drive over the period, management has positioned itself for scalable growth, which should allow it to capture the time-limited opportunity from growing ...
- Richard Williamson
Doctor Care Anywhere Group - Seizing the market opportunity
Doctor Care Anywhere Group’s (DOC) Q321 results highlight that revenue has continued to grow throughout the year, with performance in Q3 driven by a return to q-o-q growth in consultations. Following positive momentum, management has reiterated guidance for FY21 of at least 100% y-o-y organic revenue growth. Through its continuing GP recruitment drive over the period, management has positioned itself for scalable growth, which should allow it to capture the time-limited opportunity from growing ...
- Richard Williamson
Doctor Care Anywhere Group - Delivering on another IPO commitment
Doctor Care Anywhere (DOC) has delivered on another IPO commitment, entering the Australian telehealth market with its acquisition of GP2U Telehealth for A$11m. The COVID-19 pandemic has created permanent structural changes in Australian healthcare, which has accelerated the adoption of telehealth, particularly for its large rural population where access to quality healthcare has historically been limited. This acquisition gives DOC a foothold in the market, where management’s experience could a...
- Richard Williamson
Doctor Care Anywhere Group - Delivering on another IPO commitment
Doctor Care Anywhere (DOC) has delivered on another IPO commitment, entering the Australian telehealth market with its acquisition of GP2U Telehealth for A$11m. The COVID-19 pandemic has created permanent structural changes in Australian healthcare, which has accelerated the adoption of telehealth, particularly for its large rural population where access to quality healthcare has historically been limited. This acquisition gives DOC a foothold in the market, where management’s experience could a...
- Richard Williamson
Doctor Care Anywhere Group - Growing momentum following record month
Doctor Care Anywhere’s (DOC) H121 results were robust, with underlying revenue increasing by 101% y-o-y to £9.2m and consultations by 130%. Growth in the second half should be driven by continued growth in consultations, which looks likely given that DOC delivered a record 35,000 in July. Looking to FY22, progress will be determined by new partnerships and new services on its platform. Notably, management has delivered on the addition of mental health services, as well as expanding its existing ...
- Richard Williamson
Doctor Care Anywhere Group - Growing momentum following record month
Doctor Care Anywhere’s (DOC) H121 results were robust, with underlying revenue increasing by 101% y-o-y to £9.2m and consultations by 130%. Growth in the second half should be driven by continued growth in consultations, which looks likely given that DOC delivered a record 35,000 in July. Looking to FY22, progress will be determined by new partnerships and new services on its platform. Notably, management has delivered on the addition of mental health services, as well as expanding its existing ...
- Richard Williamson
Doctor Care Anywhere Group - On track to meet 100% growth target
Doctor Care Anywhere Group's (DOC) Q221 update highlights that underlying revenue has continued to increase, driven by its expanding internet hospital and subsequent growth in diagnostic referrals. Management remains confident that FY21 revenue will be at least 100% above FY20 levels, implying a total revenue of at least £23.2m. Its balance sheet remains strong with net cash of £31.5m. The expected Q421 launch of its digitally integrated virtual and in-person primary care service with Nuffield H...
- Richard Williamson
Doctor Care Anywhere Group - Forecast upgrade following solid Q1 perfo...
Doctor Care Anywhere Group’s (DOC’s) Q121 update showed that it continues to grow robustly in 2021, with revenue and consultations up c 260% y-o-y, ending the period with a solid balance sheet (net cash of £35.1m). Management remains confident of the growth potential for the rest of the year and expects revenue in 2021 to grow by at least 100% above 2020 levels. We have upgraded our FY21 forecasts following a robust Q1 and the company’s upbeat outlook for 2021.
Edison Investment Research Limited: Doctor Care Anywhere Group (DOC): ...
Edison Investment Research Limited Edison Investment Research Limited: Doctor Care Anywhere Group (DOC): Initiation - DOC from home 09-Apr-2021 / 07:00 GMT/BST London, UK, 9 April 2021 Doctor Care Anywhere Group (DOC): Initiation - DOC from home Doctor Care Anywhere (DOC) is a fast-growing telehealth company focused on the private healthcare sector. 2020 was a transformational year for the company: it signed up major new partners, listed on the ASX, delivered triple-digit revenue and KPI growth and ended 2020 with strong balance sheet (£38.4m in net cash). We believe DOC is ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.